Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Luvox CR + CT-STEPS
- Development stage
- Unknown
- Lead developer
- Jazz Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Luvox CR + CT-STEPS is a combination therapy consisting of the pharmaceutical drug Luvox CR (fluvoxamine maleate extended-release) and a web-based cognitive-behavioral therapy (CBT) program known as CT-STEPS. Luvox CR is a selective serotonin reuptake inhibitor (SSRI) and sigma-1 receptor agonist developed by Jazz Pharmaceuticals, approved for the treatment of obsessive-compulsive disorder (OCD) and social anxiety disorder. CT-STEPS is a self-directed, computer-aided behavioral therapy system designed to provide exposure and response prevention (ERP) for patients with OCD. This combination was evaluated by the Rogers Center for Research & Training in a Phase 4 clinical trial (NCT00743834) to determine if the addition of web-based CBT enhances the efficacy and cost-effectiveness of Luvox CR monotherapy in adults with OCD.
- Brand names
- Luvox CR
- Other names
- fluvoxamine maleate extended-release + CT-STEPSLuvox CR + web-based CBTLuvox CR + Behavioral Therapy
02
Targets
SIGMAR1 (Sigma non-opioid intracellular receptor 1)SERT (Sodium-dependent serotonin transporter)
Beyond the preview
Go deeper on Luvox CR + CT-STEPS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Luvox CR + CT-STEPS.